Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).
Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).
复制标题
对溶瘤 C-核苷 2-β-D-呋喃核糖基噻唑-4-甲酰胺 (NSC-286193) 的耐药机制。
作者：
H. Jayaram;D. Cooney;R. Glazer;R. L. Dion;D. Johns
